Advisory Services Network, LLC Argenx Se Transaction History

Advisory Services Network, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$338.91 - $506.01 $35,246 - $52,625	104 New	104 $39,000
Q1 2023 May 17, 2023	SELL	$334.23 - $403.65 $83,223 - $100,508	-249 Reduced 71.14%	101 $37,000
Q4 2022 Feb 13, 2023	BUY	$342.17 - $402.31 $119,759 - $140,808	350 New	350 $132,000
Q3 2021 Nov 05, 2021	SELL	$295.0 - $350.58 $1,475 - $1,752	-5 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$257.11 - $319.92 $1,285 - $1,599	5 New	5 $2,000
Q1 2021 May 24, 2021	SELL	$268.3 - $380.31 $804 - $1,140	-3 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$215.51 - $272.51 $646 - $817	3 New	3 $1,000
Q2 2020 Aug 10, 2020	SELL	$127.44 - $232.72 $382 - $698	-3 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$108.83 - $165.23 $326 - $495	3 New	3 $0
Q4 2019 Feb 04, 2020	SELL	$106.59 - $164.21 $639 - $985	-6 Closed	0 $0
Q1 2019 May 20, 2019	BUY	$98.85 - $134.59 $593 - $807	6 New	6 $1,000

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.